Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin, and ciprofloxacin therapy.
Krishnan
R S
RS
Department of Dermatology, Baylor College of Medicine, Houston, TX, USA.
Lewis
A T
AT
Kass
J S
JS
Hsu
S
S
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy / Q000473:pathology*; D004890:Erythema / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects* / Q000627:therapeutic use; D010878:Piperacillin / Q000009:adverse effects* / Q000627:therapeutic use; D014031:Tobramycin / Q000009:adverse effects* / Q000627:therapeutic use; D014466:Ultraviolet Rays
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D010406:Penicillins; D002939:Ciprofloxacin; D014031:Tobramycin; D010878:Piperacillin; D008775:Methylprednisolone